These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22814800)

  • 41. Effectiveness of detection of intrauterine growth retardation by abdominal palpation as screening test in a low risk population: an observational study.
    Bais JM; Eskes M; Pel M; Bonsel GJ; Bleker OP
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):164-9. PubMed ID: 15358457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of foetal growth restriction using third trimester ultrasound.
    Bricker L; Mahsud-Dornan S; Dornan JC
    Best Pract Res Clin Obstet Gynaecol; 2009 Dec; 23(6):833-44. PubMed ID: 19811955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are babies of normal birth weight who fail to reach their growth potential as diagnosed by ultrasound at increased risk?
    Stratton JF; Scanaill SN; Stuart B; Turner MJ
    Ultrasound Obstet Gynecol; 1995 Feb; 5(2):114-8. PubMed ID: 7719861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early fetal growth, PAPP-A and free β-hCG in relation to risk of delivering a small-for-gestational age infant.
    Kirkegaard I; Henriksen TB; Uldbjerg N
    Ultrasound Obstet Gynecol; 2011 Mar; 37(3):341-7. PubMed ID: 20737455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The ultrasonic diagnosis of intrauterine fetal growth retardation].
    Strizhova NV; Elamin HY; Bokin IS
    Akush Ginekol (Mosk); 1992; (8-12):30-1. PubMed ID: 1292357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors and outcomes associated with first-trimester fetal growth restriction.
    Mook-Kanamori DO; Steegers EA; Eilers PH; Raat H; Hofman A; Jaddoe VW
    JAMA; 2010 Feb; 303(6):527-34. PubMed ID: 20145229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial.
    Grab D; Paulus WE; Erdmann M; Terinde R; Oberhoffer R; Lang D; Muche R; Kreienberg R
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):19-27. PubMed ID: 10776008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second-trimester fetal growth as a predictor of poor obstetric and neonatal outcome in patients with low first-trimester serum pregnancy-associated plasma protein-A and a euploid fetus.
    Fox NS; Shalom D; Chasen ST
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):34-8. PubMed ID: 19115230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abdominal circumference: a single measurement versus growth rate in the prediction of intrapartum Cesarean section for fetal distress.
    Williams KP; Nwebube N
    Ultrasound Obstet Gynecol; 2001 Jun; 17(6):493-5. PubMed ID: 11422969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized controlled trial in a hospital population of ultrasound measurement screening for the small for dates baby.
    Duff GB
    Aust N Z J Obstet Gynaecol; 1993 Nov; 33(4):374-8. PubMed ID: 8179545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal sonographic features of Russell-Silver syndrome.
    Wax JR; Burroughs R; Wright MS
    J Ultrasound Med; 1996 Mar; 15(3):253-5. PubMed ID: 8919509
    [No Abstract]   [Full Text] [Related]  

  • 52. Third trimester ultrasound. A long-standing debate.
    López Soto Á; Velasco Martínez M; Meseguer González JL; López Pérez R
    Taiwan J Obstet Gynecol; 2021 May; 60(3):401-404. PubMed ID: 33966720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antenatal screening and risk factors for intrauterine growth retardation.
    Wennergren M
    Int J Technol Assess Health Care; 1992; 8 Suppl 1():147-51. PubMed ID: 1428634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fetal presacral pseudo-mass: a normal sonographic variant.
    Karcnik TJ; Rubenstein JB; Swayne LC
    J Ultrasound Med; 1991 Oct; 10(10):579-81. PubMed ID: 1942224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A systematic review on the utility of non-invasive electrophysiological assessment in evaluating for intra uterine growth restriction.
    Smith V; Nair A; Warty R; Sursas JA; da Silva Costa F; Wallace EM
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):230. PubMed ID: 31277600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study.
    Gaccioli F; Sovio U; Cook E; Hund M; Charnock-Jones DS; Smith GCS
    Lancet Child Adolesc Health; 2018 Aug; 2(8):569-581. PubMed ID: 30119716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-Time Monitoring of Placental Oxygenation during Maternal Hypoxia and Hyperoxygenation Using Photoacoustic Imaging.
    Arthuis CJ; Novell A; Raes F; Escoffre JM; Lerondel S; Le Pape A; Bouakaz A; Perrotin F
    PLoS One; 2017; 12(1):e0169850. PubMed ID: 28081216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uncomplicated Pregnancies and Ultrasounds for Fetal Growth Restriction: A Pilot Randomized Clinical Trial.
    Hammad IA; Chauhan SP; Mlynarczyk M; Rabie N; Goodie C; Chang E; Magann EF; Abuhamad AZ
    AJP Rep; 2016 Mar; 6(1):e83-90. PubMed ID: 26929878
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.